Rua Life Sciences PLC Cash Flow Conversion Efficiency
Rua Life Sciences PLC cash flow conversion efficiency. Based on the latest financial reports, Rua Life Sciences PLC (RUA) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX29.00K ≈ $3.53 USD) by net assets (GBX7.23 Million ≈ $879.44 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Rua Life Sciences PLC (1994–2025)
Cash flow conversion efficiency of Rua Life Sciences PLC from 1994 to 2025. This chart illustrates how Rua Life Sciences PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RUA stock price and chart for real-time trading data and today's change.
Rua Life Sciences PLC Cash Flow Conversion Ratio Explained
Rua Life Sciences PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Rua Life Sciences PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rua Life Sciences PLC ranked by their cash flow conversion efficiency. Also see Rua Life Sciences PLC market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Graphjet Technology
NASDAQ:GTI
|
0.009x |
|
noco-noco Inc. Ordinary Share
NASDAQ:NCNC
|
0.000x |
|
Ground Rents Income Fund PLC
LSE:GRIO
|
0.029x |
|
ENvue Medical Inc.
NASDAQ:FEED
|
-0.087x |
|
Inspiration Healthcare Group PLC
LSE:IHC
|
0.222x |
|
ATMOFIZER TECHNOL.INC. B
F:J3KA
|
-0.019x |
|
Artisanal Spirits Company PLC
LSE:ART
|
-0.537x |
|
Mineral & Financial Investments Ltd
LSE:MAFL
|
0.012x |
Annual Cash Flow Conversion Efficiency for Rua Life Sciences PLC (1994–2025)
The table below shows the annual cash flow conversion efficiency of Rua Life Sciences PLC from 1994 to 2025. Review RUA FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | GBX7.23 Million ≈ $879.44 |
GBX-137.00K ≈ $-16.67 |
-0.019x | +36.02% |
| 2025-03-31 | GBX7.39 Million ≈ $899.39 |
GBX-219.00K ≈ $-26.65 |
-0.030x | +83.98% |
| 2024-03-31 | GBX7.18 Million ≈ $873.84 |
GBX-1.33 Million ≈ $-161.58 |
-0.185x | +26.24% |
| 2023-03-31 | GBX4.68 Million ≈ $569.79 |
GBX-1.17 Million ≈ $-142.84 |
-0.251x | +30.09% |
| 2022-03-31 | GBX6.58 Million ≈ $801.08 |
GBX-2.36 Million ≈ $-287.27 |
-0.359x | -114.35% |
| 2021-03-31 | GBX8.51 Million ≈ $1.03K |
GBX-1.42 Million ≈ $-173.14 |
-0.167x | +11.70% |
| 2020-03-31 | GBX2.27 Million ≈ $276.80 |
GBX-431.00K ≈ $-52.44 |
-0.189x | -32.48% |
| 2019-03-31 | GBX3.00 Million ≈ $365.01 |
GBX-429.00K ≈ $-52.20 |
-0.143x | -141.87% |
| 2018-03-31 | GBX1.02 Million ≈ $123.62 |
GBX347.00K ≈ $42.22 |
0.342x | +325.07% |
| 2017-03-31 | GBX1.05 Million ≈ $127.99 |
GBX-159.62K ≈ $-19.42 |
-0.152x | -318.79% |
| 2016-03-31 | GBX1.22 Million ≈ $148.59 |
GBX84.70K ≈ $10.31 |
0.069x | +158.98% |
| 2015-03-31 | GBX1.61 Million ≈ $196.39 |
GBX-189.82K ≈ $-23.10 |
-0.118x | -708.78% |
| 2014-03-31 | GBX1.65 Million ≈ $200.81 |
GBX-24.00K ≈ $-2.92 |
-0.015x | -111.36% |
| 2013-03-31 | GBX2.71 Million ≈ $329.20 |
GBX346.19K ≈ $42.12 |
0.128x | +703.72% |
| 2012-03-31 | GBX3.18 Million ≈ $386.67 |
GBX50.59K ≈ $6.16 |
0.016x | +103.25% |
| 2011-03-31 | GBX3.12 Million ≈ $379.86 |
GBX-1.53 Million ≈ $-185.79 |
-0.489x | -29.15% |
| 2010-03-31 | GBX5.41 Million ≈ $658.61 |
GBX-2.05 Million ≈ $-249.43 |
-0.379x | -67.19% |
| 2009-03-31 | GBX6.13 Million ≈ $746.09 |
GBX-1.39 Million ≈ $-169.00 |
-0.227x | -41.48% |
| 2008-03-31 | GBX7.11 Million ≈ $865.57 |
GBX-1.14 Million ≈ $-138.58 |
-0.160x | +41.90% |
| 2007-03-31 | GBX2.96 Million ≈ $360.27 |
GBX-816.00K ≈ $-99.28 |
-0.276x | -9.29% |
| 2006-03-31 | GBX5.11 Million ≈ $621.50 |
GBX-1.29 Million ≈ $-156.71 |
-0.252x | +32.73% |
| 2005-03-31 | GBX5.65 Million ≈ $687.81 |
GBX-2.12 Million ≈ $-257.82 |
-0.375x | -192.12% |
| 2004-03-31 | GBX7.57 Million ≈ $920.69 |
GBX-971.00K ≈ $-118.14 |
-0.128x | +92.57% |
| 2003-03-31 | GBX6.91 Million ≈ $840.50 |
GBX-11.93 Million ≈ $-1.45K |
-1.727x | -514.49% |
| 2002-03-31 | GBX46.21 Million ≈ $5.62K |
GBX-12.99 Million ≈ $-1.58K |
-0.281x | -135.96% |
| 2001-03-31 | GBX35.96 Million ≈ $4.38K |
GBX-4.28 Million ≈ $-521.24 |
-0.119x | -144.44% |
| 2000-03-31 | GBX41.55 Million ≈ $5.06K |
GBX-2.02 Million ≈ $-246.38 |
-0.049x | +86.06% |
| 1999-03-31 | GBX4.11 Million ≈ $499.95 |
GBX-1.44 Million ≈ $-174.72 |
-0.349x | +35.64% |
| 1998-03-31 | GBX2.52 Million ≈ $306.98 |
GBX-1.37 Million ≈ $-166.69 |
-0.543x | -77.10% |
| 1997-03-31 | GBX3.12 Million ≈ $379.37 |
GBX-956.00K ≈ $-116.32 |
-0.307x | -146.61% |
| 1996-03-31 | GBX678.00K ≈ $82.49 |
GBX446.00K ≈ $54.27 |
0.658x | +112.42% |
| 1995-03-31 | GBX44.00K ≈ $5.35 |
GBX-233.00K ≈ $-28.35 |
-5.295x | -4754.17% |
| 1994-03-31 | GBX330.00K ≈ $40.15 |
GBX-36.00K ≈ $-4.38 |
-0.109x | -- |
About Rua Life Sciences PLC
RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast… Read more